Physician profile
Thomas E Curd
NPI 1033117585
$1,151.10
in general payments reported to CMS, 2019-2025
21 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $38.21 · 2021: $50.97 · 2022: $107 · 2023: $102 · 2024: $257 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southtech Orthopedics | $252.50 | 2019 | |
| Amgen INC. | $224.90 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $198.47 | 2020-2024 | |
| Baxter Healthcare | $104.57 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Abbvie INC. | $64.85 | 2024-2025 | |
| Medtronic, INC. | $39.62 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Bioventus LLC | $24.30 | 2025 | Exogen Ultrasound Bone Healing System |
| Solventum Corporation | $23.52 | 2024 | Activ.A.C. |
| Smith+Nephew, INC. | $23.34 | 2023 | Grafix |
| Mimedx Group, INC. | $23.25 | 2025 | |
| Averitas Pharma INC. | $22.10 | 2023 | Qutenza |
| Tricoast Surgical Solutions LLC | $19.23 | 2024 | |
| Advanced Oxygen Therapy INC. | $17.28 | 2025 | Topical Oxygen Chamber For Extremities |
| Zimmer Biomet Holdings, INC. | $16.35 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.04 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cashflow Solutions, LLC | $15.19 | 2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Nabriva Therapeutics, Plc | $14.57 | 2022 | |
| Treace Medical Concepts, INC. | $14.45 | 2025 | |
| Sebela Pharmaceuticals INC. | $13.67 | 2023 | Naftin |
| Kci USA, INC. | $12.05 | 2021 | |
| Merck Sharp & Dohme LLC | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Curd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.